Welcome
Support Centre
22 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Valved oesophageal stents in patients with oesophageal carcinoma.
ISRCTN ISRCTN78960892
ClinicalTrials.gov identifier
Public title Valved oesophageal stents in patients with oesophageal carcinoma.
Scientific title
Acronym N/A
Serial number at source N0013160111
Study hypothesis Whether a valve in oesophageal stent design is beneficial?
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer: Oesophageal
Participants - inclusion criteria Randomised between stents with no valve but prescribed Omeprazole and stent with valve. Approx. 50 patients.
Participants - exclusion criteria 1. Pregnant women
2. Patients under 18 years of age
3. Patients unfit for stent insertion
Anticipated start date 27/01/2005
Anticipated end date 27/01/2006
Status of trial Completed
Patient information material
Target number of participants 50
Interventions Following stent insertion, symptomatic reflux may occur, to evaluate whether a valve may prevent this we are conducting this randomised controlled trial comparing valveless stents versus a stent with a valve. All patients entered into this study will have cancer obstructing the lower oesophagus and will be treated with metallic stents projecting into the stomach. There are two groups: One group will receive stents that have a valve that is designed to prevent stomach contents reaching the oesophagus. The other will have stents without a valve. We will look at how well the stents work at stopping reflux, how well they receive dysphagia (difficulty in swallowing) and what the complications are in each group. Subjects will be randomised using a book of random numbers.
Primary outcome measure(s) Dysphagia scores, barium reflux.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Guy's and St. Thomas' NHS Foundation Trust
Own account
NHS R&D Support Funding
Trial website
Publications
Contact name Prof  Andreas  Adam
  Address Department of Radiology
F01 Lambeth Wing
St Thomas's Hospital
Lambeth Palace Road
  City/town London
  Zip/Postcode SE1 7EH
  Country United Kingdom
  Tel +44 (0)20 7188 5550
  Fax +44 (0)20 7188 5454
  Email andy.adam@kcl.ac.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 03/10/2005
Date ISRCTN assigned 30/09/2005
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central